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Phytoconstituents from plants serve as a safe replacement for synthetic molecules in drug production. Lumnitzera 
racemosa Willd., commonly called white-flowered black mangrove, is used in folk medicine to treat inflammation and other 
diseases. Here, we evaluated the antiulcer activity of two fractions (LR-B-4-11 and LR-B-4-12) of n-butanol (n-BuOH) 
fractions of L. racemosa leaves at the doses of 50 and 100 mg/kg, body wt. against indomethacin induced gastric mucosal 
injury in Wistar rats. The rats were dissected and their stomachs were inspected macroscopically to diagnose hemorrhagic 
lesions in the gastric and fundic mucosa. Administration of the fractions at doses of 50 and 100 mg/kg body wt., 
demonstrated a significant reduction in the indomethacin induced gastric erosion when compared to the control. The lower 
dose of LR-B-4-11 fraction (50 mg/kg) resulted in better inhibition of indomethacin induced gastric ulcer as compared to the 
control. Histological studies of the fundic and gastric mucosa reported that indomethacin led to mucosal degeneration, 
ulceration, and migration of numerous inflammatory cells throughout the section. On the other hand, pretreated groups with 
n-BuOH fractions demonstrated substantial regeneration of the mucosal layer and significant prevention of hemorrhage and
edema occurrence.
Keywords: Antiulcer activity, Folk medicine, Gastric ulcers, Inflammation, Mangrove, Mucosal degeneration, White-
flowered black mangrove 
Gastric ulcer is a common serious disease that affects 
the whole gastrointestinal tract1. It strikes primarily in 
the stomach and the proximal duodenum and may 
occur in the anastomotic site of the esophagus, 
jejunum and stomach2. A peptic ulcer results from a 
disparity between some endogenous forceful factor(s) 
[hydrochloric acid, pepsin, refluxed bile, leukotrienes, 
and reactive oxygen species (ROS)] and cytoprotective 
factors, including the role of the mucus-bicarbonate 
barrier, surface-active phospholipids, prostaglandins 
(PGs), mucosal blood flow, cell regeneration, and 
migration, non-enzymatic and enzymatic antioxidants 
and certain growth factors3-6. Gastric ulcer mechanism 
as described in many scientific articles is still poorly 
understood. It is a complicated disease in which 
different risk factors may lead to increased gastric 
damage such as lifestyle stress, alcohol consumption, 
use of nonsteroidal anti-inflammatory drugs 
(NSAIDs), and drugs that stimulate the secretion of 
gastric acid and pepsin, smoking, and family 
history3,7. One of the most vital challenges in 
medicine today is the anticipation of peptic ulcers, as 
it is certainly a major human disease affecting nearly 
8 to 10 % of the world's population8, and of these 5% 
suffers from gastric ulcers3. This disease occurs more 
often in males than in females9.  
Lumnitzera racemosa Willd. (Combretaceae), 
commonly called white-flowered black mangrove, is a 
small tree located on the coast of Africa, India, 
Australia, and Asia. A fluid collected from incisions 
made in the stem is used for the treatment of itches. 
Recently, the antihypertensive activity of the plant's 
aqueous acetone extract has been stated. Marine 
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possess a range of different metabolites having 
antioxidant, anti-inflammatory, antimicrobial, antidiarrheal, 
hepatoprotective, antifeedant, insecticidal, cytotoxic, and 
antiplasmodial actions. A large number of compounds 
such as long-chain rubber like polyisoprenoid 
alcohols in leaves, flavonoids, tannins, lignans, and 
long-chain fatty acids have been recorded for this 
plant, in addition to low molecular weight 
carbohydrates10-19. 
 
Previous phytochemical study of LR-B-4-11 and 
LR-B-4-12 fractions of n-BuOH extract of  
L. racemosa leaves led to the isolation and identification 
of 9 compounds. The structures of compounds were 
determined to be myrcetin 3-O-methyl glucuronate 
(1), lumniracemoside (2), n-hexanol 1-O-rutinoside (3), 
1,3,6-tri-O-galloyl-β-D-glucopyranose (4), corilagin 
(5), myricetrin (6), mixture of myricetin 3-O-β-D-
glucopyranoside and myricetin 3-O-β-D-galactopyranoside 
(7 and 7') 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose 
(8), and quercetin 3-O-rutinoside (9)17. 
 
In study me evaluated the antiulcer activity of the 
chemical constituents of LR-B-4-11 and LR-B-4-12 
fractions of n-BuOH extract of Lumnitzera racemosa 
collect from the subtropical marine regions in 
Okinawa, Japan against indomethacin-induced gastric 
mucosal injury in Wistar rats.  
 
Materials and Methods 
 
Plant material  
The leaves of Lumnitzera racemosa were obtained 
from Okinawa, Japan. The plant was kindly identified 
by Prof. T. Shinzato. A voucher specimen of the plant 




The air dried powdered leaves of L. racemosa  
(4.1 kg) were extracted with 95% methanol until 
exhaustion and then concentrated to produce a viscous 
gummy residue under reduced pressure using Eyela 
rotary evaporator (Tokyo Rikakikai, Japan). The 
residue was dissolved in water and defatted with  
n-hexane to give a hexane layer (58.8 g). The aqueous 
layer was evaporated to remove a small quantity of  
n-hexane and then extracted with ethyl acetate 
(EtOAc) (139.1 g) and n-BuOH (89.9 g), respectively.  
The n-BuOH fraction (89.9 g) was fractionated by 
column chromatography on Diaion HP-20 (Φ=80 mm, 
L=37cm). The column was developed firstly with 
H2O, followed by MeOH–H2O stepwise gradient with 
increasing MeOH and finally with 100% MeOH. The 
identical fractions have been combined to afford eight 
fractions (LR-B-1 to LR-B-8).  
The fraction LR-B-4 (31.8 mg) was chromatographed 
over silica gel (900 g), (Ф = 80 mm, L = 44 cm), 
using CHCl3, then CHCl3–MeOH gradient system. 
The related fractions have been combined producing 
14 fractions (LR-B-4-1 to LR-B-4-14).  
 
Antiulcer activity experiment 
Thirty-six male Wistar rats were purchased from 
Animal house, Faculty of Agriculture, Department of 
Agricultural Chemistry, Minia University, Egypt. The 
animals received 2 weeks of acclimation duration, 
during which they were fed a regular rat pellet diet 
and water ad libitum, with an alternating 12 h 
dark/light cycle, and a steady ambient temperature of 
21 and 25°C. They were kept separately in cages for 
different six groups (6 rats each), and each group had 
a mean weight of 147±2 g. The food was removed the 
day before the injection, with free access to water. All 
experiments were conducted on experimental animals 
were approved by the Commission on the Ethics of 
Scientific Research, Faculty of Pharmacy, Minia 
University, Egypt (Project code No. 46/2019). Six rats 
per group were distributed randomly up to the mean 
weight distribution, as follows: Protective treated 
Groups I & II: administered with indomethacin  
and LR-B-4-11 fraction (1% DMSO) at 50 and  
100 mg/kg body wt. orally once daily in the morning, 
respectively; similarly, Groups. III & IV: admininistered 
with indomethacin and LR-B-4-12 fraction (1% DMSO) 
at 50 and 100 mg/kg body wt. orally once daily in the 
morning; and Group V indomethacin group in which 
gastric ulceration was induced by intraperitoneal (i.p.) 
injection of a single dose of 30 mg/ kg/body wt.20;  
and Group VI, DMSO group administered with 1% 
DMSO orally once daily in the morning. 
Indomethacin oral administration (30 mg/kg/ body 
wt.) for Groups I-IV were followed the morning oral 
protection treatments either with (LR-B-4-11 and LR-
B-4-12) fractions by 30 min. Food intake and body 
weight were determined and the biological experiment 
has lasted for 10 days. The animals were sacrificed 
and the stomach was excised and cut along the greater 
curvature for all animals and washed carefully with  
5 mL of 0.9% NaCl. Histological examination was 
studied to determine the severity of the ulcers21.  
 
Gastric secretion study 
The collected gastric juice from the stomach of rats 
was centrifuged and the supernatant was expressed  
in terms of mL/100 g body wt. One milliliter of  




gastric juice was pipetted into a 100 mL conical  
flask, two or three drops of Topfer’s reagent were 
added and this was titrated with 0.01 N NaOH until 
the colour of the solution changed from red to 
yellowish orange. The volume of added alkali was 
observed. This volume is equivalent to free acidity. 
Two or three drops of a solution of phenolphthalein 
were added and continued the titration till a definite 
red colour tinge developed. The total volume of alkali 
added was noted. The volume represents the total 






Animals were sacrificed at the end of the 
experiments, while they were under isoflurane (5% in 
100% oxygen) anesthesia. For the histological 
investigation, specimens of each rat's gastric walls 
were stored in 10% buffered formalin for 24 h, 
following the antiulcer activity evaluation. The tissue 
specimens were then handled for paraffin embedding 
tissue sections. The samples were cut using a  
Minux-rotary microtome, followed by staining with 
Hematoxylin and Eosin (H & E) and mounted on 
Canada balsam. All sections were examined under a 
light microscope. Photographs of the lesions were 
taken using an Olympus photo microscope to detect 
and record histopathological changes, such as edema, 
inflammation, infiltration, and erosion, etc.24. 
 
Induction of ulcer  
The animals were denied access to any nutrition for 
a day and were only allowed access to drinking  
water for two hours prior to the beginning of the 
experiment. The rats were placed individually in 
separate cages during the fasting period to prevent 
coprophagy. Thirty minutes after pre-treatment with 
test samples (50 and 100 mg/kg body wt.), gastric 
ulcers induced using a single dose of 30 mg/ kg body 
wt. indomethacin20. 
 
Solvents and chemicals 
Indomethacin was purchased from Nile Co., for 
Pharmaceutical Industries (Cairo, Egypt). The other 
chemicals used were of good quality and analytical 
grade.  
 
Statistical analysis  
The collected data were statistically analyzed using 
the ANOVA procedure (Excel, 2016). The significance 




Effect of n-BuOH extract of L. racemosa leaves on gastric 
secretion 
The effects of LR-B-4-11 and LR-B-4-12 fractions 
of n-BuOH extract of L. racemosa leaves at doses of 
50 and 100 mg/kg on pH, free and total acidity was 
studied by collecting gastric juice from stomachs. As 
shown in Table 1, treatment with LR-B-4-11 and LR-
B-4-12 fractions at a dose of 50 mg/kg body weight 
has significantly reduced the free acidity by 44.91 and 
32.05%, respectively, and accompanied by significant 
reductions in volumes of gastric juice and gastric pH 
(Table 1). On the other side, a dose of 100 mg/kg 
body wt. has decreased the total acidity by 30.41 and 
31.44 %, respectively compared to control (Table 1).  
 
Macroscopic examination of gastric lesions 
Indomethacin caused lesions manifested by thick 
blackish areas scattered over the major part of the 
mucosa, compared to the normal control (Fig. 1). 
Table 1 — Estimation of pH, free acidity and total acidity of gastric juice 
Treatment Volume of gastric juice 
(mL) 
pH Free acidity  
(meq/L/100 g) 
Total acidity  
(meq/L/100 g) 
LR-B-4-11 (50 mg/kg) 4.06±0.08 1.51±0.08 15.21±1.94 60.60±2.176 
LR-B-4-11 (100 mg/kg) 3.46±0.05 2.10±0.05 21.49±0.42 54.60±1.430* 
LR-B-4-12 (50 mg/kg) 4.70±0.15 1.80±0.15 18.76±0.55 57.00±1.167* 
LR-B-4-12 (100 mg/kg) 3.73±0.02 2.23±0.02 22.31±2.34 53.20±0.32 
IND (30 mg/kg) DMSO 1% 1.25±0.23 1.89±0.43 1.30±0.21 2.76±0.34 24.13±1.65 27.61±2.71 66.30±2.14 77.60±3.23 




Fig. 1 — Gross appearance of the gastric mucosa in pretreated group with: (A) LR-B-4-11, 50 mg/kg body wt.; (B) LR-B-4-11, 
100 mg/kg body wt.; (C) LR-B-4-12, 50 mg/kg b.w.; (D) LR-B-4-12, 100 mg/kg body wt.; (E) indomethacin; and (F) DMSO (control 
group). [U:  marked ulcers along with haemorrhagic streaks and mucosal damage were observed and MI:  mild injuries] 




Mild ulcerations were observed after pre-treatment 
with LR-B-4-11 and LR-B-4-12 fractions of n-BuOH 
extract of L. racemosa leaves, especially at the dose of 
100 mg/kg (Fig. 1 B & D). At the dose of 50 mg/kg, the 
fractions exhibited remarkable inhibition of 
indomethacin-induced ulcers. (Fig. 1 A & C) 
 
Histological evaluation of gastric lesions  
The effects of LR-B-4-11 and LR-B-4-12 fractions 
of n-BuOH extract of L. racemosa leaves at doses of 
50 and 100 mg/kg on various histopathological 
parameters in indomethacin-induced gastric ulcer 
compared to other groups are shown in Table. 2. The 
fraction LR-B-4-11 at the lower dose (50 mg/kg) 
exhibited better inhibition of indomethacin-induced 
gastric ulcer as compared to the control. 
 
A photomicrograph of a section in fundic mucosa 
is shown in Fig. 2. Group VI showed fundic gland 
with apical surface epithelium with clear boundaries 
and muscularis mucosa (Fig. 2F).  
 
The histological section of the gastric mucosa is 
shown in Fig. 3. Group VI displayed some collagen 
deposition in submucosa (Fig. 3F). Whereas the 
indomethacin group V demonstrated ulceration 
throughout the gastric mucosal section (Fig. 3E) and 
showed intact gastric surface mucus layer, inflammatory 
cell infiltration, local congestion, and edema in lamina 
propria in the section of fundic mucosa (Fig. 2E). 
However, administration of n-BuOH fractions (LR-B-
4-11 and LR-B-4-12) at the lower concentration  
(50 mg/kg body wt.) showed a significant  
change in histopathology of the fundic mucosa (Fig. 2 
A & C), compared to the higher concentration (100 
mg/kg) (Fig. 2 B & D). The histopathology of the 
gastric mucosa for the n-BuOH fractions (LR-B-4-11 
and LR-B-4-12) at the lower concentration (50 
mg/kg) presented some collagen deposition in sub 
mucosa (Fig. 3A) and few collagen fibers in the 
lamina propria between the basal parts of the fundic 
glands and in sub mucosal areas (Fig. 3C). On the 
other hand, the photomicrograph of the gastric 
mucosa at the higher concentration of (LR-B-4-11 and 
LR-B-4-12) displayed ulcer (U) with very thick 
collagen fibers in submucosal areas (Fig. 2 B & D and 
Fig. 3 B & D).  
Table 2 — Effects of n-BuOH fractions of L. racemosa leaves on 










LR-B-4-11 (50 mg/kg) - - - - 
LR-B-4-11 (100 mg/kg) +++ +++ +++ +++ 
LR-B-4-12 (50 mg/kg) - + + + 
LR-B-4-12 (100 mg/kg) ++ +++ +++ +++ 
IND (30 mg/kg) - ++ ++ ++ 
DMSO 1% - - + - 
Present (+); Non present (-); BV, Blood vessels 
 
 
Fig. 2 — A photometric of a section in fundic mucosa in pretreated group with: (A) LR-B-4-11, 50 mg/kg body wt.; (B) LR-B-4-11, 100 mg/kg 
body wt.; (C) LR-B-4-12, 50 mg/kg body wt.; (D) LR-B-4-12, 100 mg/kg body wt.; (E) indomethacin; and (F) DMSO (control group). [Each
group was assessed at 400X magnification (H&E, scale bar=200 μm); :clear boundaries, M: muscularis mucosa, BV: congested blood vessels
in submucosa, L: loss of some cells in the basal part of the fundic gland, *: submucosal odema and U: gastric ulcer] 





Indomethacin, an NSAID, is a significant risk factor 
for gastric ulcers. It works principally by preventing 
the activity of cyclooxygenase enzyme, resulting in a 
reduction of prostaglandins synthesis25. The use of 
NSAIDs could cause damage to gastric and duodenal 
mucosa through a diversity of mechanisms, for 
example, irritation of epithelium by these drugs, 
impairment of mucosal membrane barrier properties, 
inhibition of prostaglandins production, reduction of 
gastric mucosal blood flow, and interference with 
superficial injury repair26. Prostaglandins typically 
impart cytoprotective influence on the mucosal layer, 
since they suppress hydrochloric acid and activate 
secretions of protective factors such as mucus and 
bicarbonate. The indomethacin-caused disturbance of 
the mucosal defense system lets gastric acid directly 
erode the mucosal layer27. 
 
The phytochemical examination of L. racemosa 
methanolic extract showed the presence of alkaloids, 
phenols, steroids, triterpenoids, flavonoids, and 
coumarins. Several studies have documented the 
protective effects of some terpenoids, steroids and 
phenolic compounds (tannins, coumarins and 
flavonoids) due to their antioxidant properties. Recently, 
a variety of natural products have been extensively 
explored and exposed to clinical trials to develop anti-
inflammatory agents28,29. The presence of major 
phytoconstituents in the n-BuOH extract of leaves of L. 
racemosa makes it a promising candidate for promote 
the survey. The phytochemical study of  LR-B-4-11 and 
LR-B-4-12 fractions led to the identification of 9 
compounds; myrcetin 3-O-methyl glucuronate, 
lumniracemoside, n-hexanol 1-O-rutinoside, 1,3,6-tri-O-
galloyl-β-D-glucopyranose, corilagin, myricetrin, 
mixture of myricetin 3-O-β-D-glucopyranoside and 
myricetin 3-O-β-D-galactopyranoside, 1,2,3,4,6-penta-
O-galloyl-β-D-glucopyranose, and quercetin 3-O-
rutinoside17. These compounds play a very important 
role as antioxidant, antiulcer, and anti-inflammatory 
agents that could be the reason for the antiulcer activity 
of L. racemosa leaves extract.  
 
Conclusion 
The n-BuOH extract of Lumnitzera racemosa 
leaves showed protection against characteristic lesions 
caused by indomethacin administration. The dose of 
50 mg/kg showed a higher level of cytoprotection. 
This antiulcer activity may have occurred due to the 
identified nine compounds. The antiulcerogenic effect 
of the extract may be due to the reduction of gastric 
acid secretion and gastric cytoprotection. However, 
the mechanisms behind these events are still 
unknown. Further studies are required to determine 
their precise mechanism of action on gastric acid 
secretion and gastric cytoprotection. 
 
 
Fig. 3 — Histological section of gastric mucosa in pretreated group with: (A) LR-B-4-11, 50 mg/kg body wt.; (B) LR-B-4-11, 100 mg/kg 
body wt.; (C) LR-B-4-12, 50 mg/kg body wt.; (D) LR-B-4-12, 100 mg/kg body wt.; (E) indomethacin; and (F) DMSO (control group).
[Each group was assessed at 400X magnification (H&E, scale bar=200 μm); :clear boundaries, M: muscularis mucosa, BV: congested
blood vessels in submucosa, L: loss of some cells in the basal part of the fundic gland, *: submucosal odema and U: gastric ulcer] 
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